Wallkill Biopharma, Inc.
Records under this name other than the patents Wallkill Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 5 of 5 · Back to Wallkill Biopharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,696,950 | Treating Diabetes with Genetically Modified Beta Cells Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,982,190 | Genetically Modified Stem Cells Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,186,827 | Genetically Modified Stem Cells Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,739,298 | Genetically Modified Stem Cells Formerly held In force · Low confidence | In force | Low confidence | |
| US 12,365,876 | Genetically Modified Stem Cells Formerly held In force · Low confidence | In force | Low confidence |